Rhenman & Partners Asset Management AB

Latest statistics and disclosures from Rhenman & Partners Asset Management AB's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are UNH, HZNP, VRTX, JAZZ, ANTM, and represent 14.80% of Rhenman & Partners Asset Management AB's stock portfolio.
  • Added to shares of these 10 stocks: BIIB (+$24M), VEEV (+$20M), PFE (+$20M), INOV (+$13M), SGEN (+$12M), PHR (+$12M), SAVA (+$9.8M), VRTX (+$9.6M), RCM (+$7.8M), HCAT (+$6.9M).
  • Started 9 new stock positions in PFE, SAGE, SBTX, PGNY, INNV, THC, HRMY, IMCR, SAVA.
  • Reduced shares in these 10 stocks: JNJ (-$41M), BMY (-$13M), NVCR (-$13M), LIVN (-$12M), LLY (-$12M), CNC (-$12M), BDX (-$9.0M), MDT (-$7.7M), HZNP (-$6.6M), BAX (-$6.4M).
  • Sold out of its positions in ADVM, ALXN, AMWL, GDRX, NXGN, NUAN, RPRX.
  • Rhenman & Partners Asset Management AB was a net seller of stock by $-25M.
  • Rhenman & Partners Asset Management AB has $1.5B in assets under management (AUM), dropping by 2.72%.
  • Central Index Key (CIK): 0001599882

Tip: Access up to 7 years of quarterly data

Positions held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Rhenman & Partners Asset Management AB

Companies in the Rhenman & Partners Asset Management AB portfolio as of the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
UnitedHealth (UNH) 3.4 $50M +10% 125k 400.44
Horizon Therapeutics Pub L SHS (HZNP) 3.3 $49M -11% 525k 93.64
Vertex Pharmaceuticals Incorporated (VRTX) 3.0 $44M +28% 216k 201.63
Jazz Pharmaceuticals Shs Usd (JAZZ) 2.7 $39M -12% 220k 177.64
Anthem (ANTM) 2.5 $36M 95k 381.80
Abbvie (ABBV) 2.4 $36M -13% 320k 112.64
Teladoc (TDOC) 2.4 $35M +10% 210k 166.29
Medtronic SHS (MDT) 2.3 $34M -18% 273k 124.13
CVS Caremark Corporation (CVS) 2.2 $32M -15% 380k 83.44
Biogen Idec (BIIB) 2.1 $31M +361% 90k 346.27
Cigna Corp (CI) 2.1 $31M +18% 131k 237.07
Abbott Laboratories (ABT) 2.0 $29M -9% 250k 115.93
Eli Lilly & Co. (LLY) 1.9 $27M -30% 119k 229.52
Mirati Therapeutics (MRTX) 1.8 $27M +10% 165k 161.53

Setup an alert

Rhenman & Partners Asset Management AB will file the next quarterly 13-HR in about 2 months. Would you like to be notified?

Novocure Ord Shs (NVCR) 1.8 $27M -33% 120k 221.82
Thermo Fisher Scientific (TMO) 1.7 $25M +11% 50k 504.48
Acceleron Pharma (XLRN) 1.7 $25M +25% 200k 125.49
Seagen (SGEN) 1.7 $25M +97% 158k 157.88
Humana (HUM) 1.7 $24M -20% 55k 442.73
Axonics Modulation Technolog (AXNX) 1.6 $24M -7% 380k 63.41
Merck & Co (MRK) 1.6 $23M +11% 300k 77.77
Veeva Sys Cl A Com (VEEV) 1.6 $23M +581% 75k 310.95
Alnylam Pharmaceuticals (ALNY) 1.6 $23M 135k 169.52
Zimmer Holdings (ZBH) 1.5 $23M +7% 140k 160.82
Boston Scientific Corporation (BSX) 1.5 $22M -22% 520k 42.76
Guardant Health (GH) 1.5 $22M -22% 175k 124.19
Intuitive Surgical Com New (ISRG) 1.4 $21M -22% 23k 919.64
Gilead Sciences (GILD) 1.4 $21M -14% 300k 68.86
Inovalon Hldgs Com Cl A (INOV) 1.4 $20M +179% 600k 34.08
Abiomed (ABMD) 1.4 $20M -16% 65k 312.11
AmerisourceBergen (ABC) 1.3 $20M +3% 173k 114.49
Pfizer (PFE) 1.3 $20M NEW 500k 39.16
Biohaven Pharmaceutical Holding (BHVN) 1.3 $20M 200k 97.08
Apellis Pharmaceuticals (APLS) 1.3 $19M +12% 305k 63.20
EXACT Sciences Corporation (EXAS) 1.3 $19M -11% 155k 124.31
Centene Corporation (CNC) 1.3 $19M -38% 260k 72.93
Cooper Cos Com New (COO) 1.2 $18M -10% 45k 396.27
Intra Cellular Therapies (ITCI) 1.2 $18M -6% 430k 40.82
Nektar Therapeutics (NKTR) 1.1 $16M -27% 950k 17.16
Accolade (ACCD) 1.1 $16M +50% 300k 54.31
Phreesia (PHR) 1.1 $16M +333% 260k 61.30
Hca Holdings (HCA) 1.1 $16M 75k 206.75
McKesson Corporation (MCK) 1.0 $15M -11% 78k 191.24
Macrogenics (MGNX) 1.0 $15M 545k 26.86
Regeneron Pharmaceuticals (REGN) 0.9 $14M +25% 25k 558.56
BioMarin Pharmaceutical (BMRN) 0.9 $13M -11% 160k 83.44
Health Catalyst (HCAT) 0.9 $13M +108% 240k 55.51
Johnson & Johnson (JNJ) 0.8 $12M -76% 75k 164.75
R1 Rcm (RCM) 0.8 $12M +175% 550k 22.24
Esperion Therapeutics (ESPR) 0.8 $12M -3% 572k 21.15
Aerie Pharmaceuticals (AERI) 0.8 $12M 750k 16.01
Xencor (XNCR) 0.8 $12M +44% 340k 34.49
Becton, Dickinson and (BDX) 0.8 $12M -43% 48k 243.19
Edwards Lifesciences (EW) 0.8 $11M 110k 103.57
1life Healthcare (ONEM) 0.7 $11M +65% 330k 33.06
Neurocrine Biosciences (NBIX) 0.7 $10M -32% 105k 97.32
Cassava Sciences (SAVA) 0.7 $9.8M NEW 115k 85.44
Sangamo Biosciences (SGMO) 0.6 $9.2M 765k 11.97
Baxter International (BAX) 0.6 $8.9M -42% 110k 80.50
Bristol Myers Squibb (BMY) 0.6 $8.4M -61% 125k 66.82
ImmunoGen (IMGN) 0.5 $8.0M +121% 1.2M 6.59
Revance Therapeutics (RVNC) 0.5 $8.0M +22% 270k 29.64
Radius Health Com New (RDUS) 0.5 $7.8M 430k 18.24
Iovance Biotherapeutics (IOVA) 0.5 $7.8M 300k 26.02
Alkermes SHS (ALKS) 0.5 $7.6M +47% 309k 24.52
Essa Pharma Com New (EPIX) 0.5 $7.4M 260k 28.57
Dynavax Technologies Corp Com New (DVAX) 0.5 $7.4M -4% 750k 9.85
G1 Therapeutics (GTHX) 0.5 $7.1M 325k 21.94
Silk Road Medical Inc Common (SILK) 0.5 $7.0M 146k 47.86
Meiragtx Holdings (MGTX) 0.5 $7.0M 450k 15.50
Stereotaxis Com New (STXS) 0.4 $6.6M 684k 9.64
Rigel Pharmaceuticals Com New (RIGL) 0.4 $6.6M 1.5M 4.34
Shockwave Med (SWAV) 0.4 $6.4M -32% 34k 189.73
Phathom Pharmaceuticals (PHAT) 0.4 $6.3M +6% 186k 33.85
Zai Lab Adr (ZLAB) 0.4 $6.2M -22% 35k 177.00
Tenet Healthcare Corp Com New (THC) 0.4 $5.7M NEW 85k 66.99
Myovant Sciences (MYOV) 0.4 $5.7M +11% 250k 22.77
Annexon (ANNX) 0.4 $5.6M +38% 250k 22.51
Oak Street Health (OSH) 0.4 $5.6M -17% 95k 58.57
Fibrogen (FGEN) 0.4 $5.3M 200k 26.63
Viewray Adr (VRAY) 0.3 $5.1M 775k 6.60
Progyny (PGNY) 0.3 $4.7M NEW 80k 59.00
Sage Therapeutics (SAGE) 0.3 $4.3M NEW 75k 56.81
Arena Pharmaceuticals Com New (ARNA) 0.3 $4.1M 60k 68.20
Immunocore Hldgs Ads (IMCR) 0.2 $3.5M NEW 90k 39.06
Innovage Hldg Corp (INNV) 0.2 $3.2M NEW 150k 21.31
Silverback Therapeutics (SBTX) 0.2 $3.1M NEW 100k 30.89
Ionis Pharmaceuticals (IONS) 0.2 $3.0M 75k 39.89
Glaukos (GKOS) 0.2 $3.0M 35k 84.83
Harmony Biosciences Hldgs In (HRMY) 0.2 $2.8M NEW 100k 28.23
Epizyme (EPZM) 0.1 $2.2M 265k 8.31
Deciphera Pharmaceuticals (DCPH) 0.1 $2.2M 60k 36.62
Pieris Pharmaceuticals (PIRS) 0.1 $1.1M 300k 3.83
Livanova SHS (LIVN) 0.1 $841k -93% 10k 84.10

Past Filings by Rhenman & Partners Asset Management AB

SEC 13F filings are viewable for Rhenman & Partners Asset Management AB going back to 2013

View all past filings